Point Nine Capital
-
DATABASE (745)
-
ARTICLES (491)
Orient Hontai Capital is a subsidiary of Shanghai Orient Securities Capital. HQ is in Beijing.Founded in 2014, it has invested in many companies both in and outside China and mainly focuses on TMT and healthcare areas. Cases closed includes: 1. Invest Shanda games, $430MM, 23% shares, Sep. 2014;2. Acquire CMGE and delist it from Nasdaq, $365MM, 48% shares, July 2015;3. Acquire FunPlus game business, $288MM, 32% shares, Sep. 2015;
Orient Hontai Capital is a subsidiary of Shanghai Orient Securities Capital. HQ is in Beijing.Founded in 2014, it has invested in many companies both in and outside China and mainly focuses on TMT and healthcare areas. Cases closed includes: 1. Invest Shanda games, $430MM, 23% shares, Sep. 2014;2. Acquire CMGE and delist it from Nasdaq, $365MM, 48% shares, July 2015;3. Acquire FunPlus game business, $288MM, 32% shares, Sep. 2015;
Marinya Capital is the family office ofJohn B Fairfax from the Australian Fairfax family, who originally established Fairfax Media, a large media company. Marinya largely invests in property and agricultural businesses but has also made at least two investments in tech startups and in an Australian VC. Its most recent disclosed investments were in the $4.7m July 2021 seed funding round of NovoNutrients, the US-based biotech producer of alt-protein using fermentation and CO2 and other emissions, and in the $55m Series B round of Australia’s premier plant-based brand v2food in 2020.
Marinya Capital is the family office ofJohn B Fairfax from the Australian Fairfax family, who originally established Fairfax Media, a large media company. Marinya largely invests in property and agricultural businesses but has also made at least two investments in tech startups and in an Australian VC. Its most recent disclosed investments were in the $4.7m July 2021 seed funding round of NovoNutrients, the US-based biotech producer of alt-protein using fermentation and CO2 and other emissions, and in the $55m Series B round of Australia’s premier plant-based brand v2food in 2020.
The independent VC arm of Legend Holdings, Legend Capital currently manages several USD funds and RMB funds with over RMB 26 billion in assets under management. It focuses on early- and expansion-stage investment and has invested in over 300 companies as of 2016, of which more than 40 were exited via IPO, and around 40 were exits through M&A.
The independent VC arm of Legend Holdings, Legend Capital currently manages several USD funds and RMB funds with over RMB 26 billion in assets under management. It focuses on early- and expansion-stage investment and has invested in over 300 companies as of 2016, of which more than 40 were exited via IPO, and around 40 were exits through M&A.
Omnes Capital is a Paris-based private equity firm founded within the French banking group Crédit Agricole in 1999. The firm has invested in over 450 businesses across various sectors, managing assets of valuations totalling over €3.4 billion.within the French banking group Crédit Agricole in 1999. The firm has invested in over 450 businesses across various sectors, managing assets of valuations totalling over €3.4 billion.
Omnes Capital is a Paris-based private equity firm founded within the French banking group Crédit Agricole in 1999. The firm has invested in over 450 businesses across various sectors, managing assets of valuations totalling over €3.4 billion.within the French banking group Crédit Agricole in 1999. The firm has invested in over 450 businesses across various sectors, managing assets of valuations totalling over €3.4 billion.
Welight Capital was founded by former senior executive at Tencent Wu Xiaoguang in 2015. The firm invests mainly in early-stage startups in the sectors of IoT, corporate services, finance, education, consumption upgrade, retail and e-commerce.
Welight Capital was founded by former senior executive at Tencent Wu Xiaoguang in 2015. The firm invests mainly in early-stage startups in the sectors of IoT, corporate services, finance, education, consumption upgrade, retail and e-commerce.
Established by Chinese Academy of Sciences Holdings Co., Ltd., and several other conglomerates in 2011, Cash Capital invests mainly in high-tech startups in the IoT, intelligent manufacturing, mobile internet, big data, artificial intelligence, fintech, healthcare, medical equipment and pharmaceutical sectors. The firm manages assets of more than RMB 10 billion and has invested in nearly 100 companies.
Established by Chinese Academy of Sciences Holdings Co., Ltd., and several other conglomerates in 2011, Cash Capital invests mainly in high-tech startups in the IoT, intelligent manufacturing, mobile internet, big data, artificial intelligence, fintech, healthcare, medical equipment and pharmaceutical sectors. The firm manages assets of more than RMB 10 billion and has invested in nearly 100 companies.
Cheers Capital Partners is a PE investment firm focusing on early- and growth-stage investment in internet, IT, culture & media and consumption & retail sectors.
Cheers Capital Partners is a PE investment firm focusing on early- and growth-stage investment in internet, IT, culture & media and consumption & retail sectors.
Established in 1985, venture capital firm DFJ has invested in more than 300 companies throughout the world. Its core funds have raised US$4 billion to date.
Established in 1985, venture capital firm DFJ has invested in more than 300 companies throughout the world. Its core funds have raised US$4 billion to date.
Founded in 2011 by former Kingsoft CFO Wang Donghui (Kelvin Wang), Koubei and Wacai founder and former Alibaba executive Li Zhiguo (Frank Li) and another former top Alibaba executive (head of corporate finance and VP) Andrew Teoh (Zhao Hong). Ameba Capital is a seed/early stage VC fund managing over RMB 1 billion. It has invested in more than 60 startups, including Didi, Dianping and Mogujie.
Founded in 2011 by former Kingsoft CFO Wang Donghui (Kelvin Wang), Koubei and Wacai founder and former Alibaba executive Li Zhiguo (Frank Li) and another former top Alibaba executive (head of corporate finance and VP) Andrew Teoh (Zhao Hong). Ameba Capital is a seed/early stage VC fund managing over RMB 1 billion. It has invested in more than 60 startups, including Didi, Dianping and Mogujie.
Founded in 2013, Gaorong Capital is based in Beijing, with an additional office in Hong Kong. It invests primarily in early-stage and growth-stage startups in the TMT sector. Gaorong Capital’s backers include successful entrepreneurs and former investors in other world-class funds. It runs four US$ investment funds, three RMB investment funds and manages around RMB 11 billion.
Founded in 2013, Gaorong Capital is based in Beijing, with an additional office in Hong Kong. It invests primarily in early-stage and growth-stage startups in the TMT sector. Gaorong Capital’s backers include successful entrepreneurs and former investors in other world-class funds. It runs four US$ investment funds, three RMB investment funds and manages around RMB 11 billion.
Founded in Nairobi in 2017, Chandaria Capital invests in African tech and non-tech startups across market segments. It currently has 13 companies in its portfolio. Recent investments include Kenyan diagnostics medtech startup Ilhara Health’s $3.8m Series A round in 2020 and $735,000 seed funding in 2019. The VC has also joined the seed investment round for Kenyan food and beverage startup Savannah Brand in 2019.
Founded in Nairobi in 2017, Chandaria Capital invests in African tech and non-tech startups across market segments. It currently has 13 companies in its portfolio. Recent investments include Kenyan diagnostics medtech startup Ilhara Health’s $3.8m Series A round in 2020 and $735,000 seed funding in 2019. The VC has also joined the seed investment round for Kenyan food and beverage startup Savannah Brand in 2019.
Founded in Hong Kong in 2018, Lake Bleu Capital currently operates in both Hong Kong and Shanghai. With assets worth billions of US dollars under management, it mainly invests in pharmaceuticals, biotech, medical devices and healthcare services companies in Asia, especially Greater China. Its limited partners include sovereign wealth funds, university endowments, foundations, pension funds, and family offices across the world.With a long-term investment strategy, Lake Bleu Capital invests through both public and private equity with a focus on mid- to late-stage companies.
Founded in Hong Kong in 2018, Lake Bleu Capital currently operates in both Hong Kong and Shanghai. With assets worth billions of US dollars under management, it mainly invests in pharmaceuticals, biotech, medical devices and healthcare services companies in Asia, especially Greater China. Its limited partners include sovereign wealth funds, university endowments, foundations, pension funds, and family offices across the world.With a long-term investment strategy, Lake Bleu Capital invests through both public and private equity with a focus on mid- to late-stage companies.
Chairman of the Board, co-founder, co-inventor of NovoNutrients
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Founded in London in 1998, Kreos Capital is a pioneer growth debt provider. Kreos has completed over 630 deals worth over €3bn in pan-European countries and Israel. The Kreos Capital Group of companies and various funds are regulated by the Jersey Financial Services Commission.Kreos currently has 102 companies in its portfolio and has managed over 200 exits. Investee Riskified, an Israeli e-commerce fraud protection company, was listed on the NYSE at a $3.3bn valuation in August 2021. Kreos also joined recent investments in 2021 including the $54m Series B round of Austrian refurbished electronics goods marketplace Refurbed and the €9.5m round of Berlin-based HRtech expertlead.
Founded in London in 1998, Kreos Capital is a pioneer growth debt provider. Kreos has completed over 630 deals worth over €3bn in pan-European countries and Israel. The Kreos Capital Group of companies and various funds are regulated by the Jersey Financial Services Commission.Kreos currently has 102 companies in its portfolio and has managed over 200 exits. Investee Riskified, an Israeli e-commerce fraud protection company, was listed on the NYSE at a $3.3bn valuation in August 2021. Kreos also joined recent investments in 2021 including the $54m Series B round of Austrian refurbished electronics goods marketplace Refurbed and the €9.5m round of Berlin-based HRtech expertlead.
Clime Capital is a clean energy-focused investment firm based in Singapore with a focus on early-stage companies. In June 2020, the VC launched the Southeast Asia Clean Energy Facility (SEACEF), a fund backed by philanthropic donors to support early-stage companies in commercializing clean energy solutions. The initial fund is valued at $10m. SEACEF’s first investment is in Xurya, an Indonesian startup providing solar power system leasing to commercial customers.
Clime Capital is a clean energy-focused investment firm based in Singapore with a focus on early-stage companies. In June 2020, the VC launched the Southeast Asia Clean Energy Facility (SEACEF), a fund backed by philanthropic donors to support early-stage companies in commercializing clean energy solutions. The initial fund is valued at $10m. SEACEF’s first investment is in Xurya, an Indonesian startup providing solar power system leasing to commercial customers.
Calling Factorial “the Zendesk of HR," Silicon Valley heavyweight CRV led the round, in its first-ever investment in Spain
In China, coding education for children is in demand – but investors are wary
Coding lessons are most wanted by Chinese parents for their kids after English tuition, so hundreds of coding edtech startups have joined the fray
MBiz: Working toward the "tipping point" of e-procurement mainstreaming
Trusted by multinationals and conglomerates, Mbiz wants to take e-procurement mainstream by also working with municipal governments
Future Food Asia 2021: Agrifood tech at an inflection point
Agrifood tech startups urged to harness consumer, investor and government feedback to create plentiful, nutritious food through sustainable means, but exercise caution when considering IPOs
Intelligent Learning: math app helps students improve their exam score in weeks
Intelligent Learning prepares K7–11 math students for the national senior high school entrance exam, or "zhongkao," by trawling through past questions and predicting what might be tested
Plantruption: Transforming Irish seaweed into sustainable alt-protein seafood
Using abundant local seaweed as highly nutritious, eco-friendly alternatives to fish, the Dublin-based startup is gearing up to tap into new markets in Europe and the US
Financial planning startup Halofina raises pre-Series A from Mandiri Capital, Finch Capital
The funding is meant to “bridge” the company toward a 2020 Series A round as it launches a new subscription plan and works with financial advisors
Neil Shen: The super unicorn hunter
His bet on ByteDance, the startup that gave the world TikTok, helped Neil Shen top this year's Forbes Midas List. But for Shen, even in that deal he once made the wrong call
Accelerating Asia's Amra Naidoo: We’re at an inflection point in Southeast Asia
Accelerating Asia’s co-founder Amra Naidoo reveals how the program adapts its curriculum to meet startups’ needs and the challenges accelerator programs face during the pandemic
Future Food Asia 2021: Fireside chat with Green Monday's David Yeung
For Chinese startup Green Monday, it’s important to resonate with different local audiences by adapting to local culture and dietary habits and continuously fine-tuning existing products
Indexa Capital: Investment opportunities for the everyman
Spanish startup Indexa Capital has created an automated wealth manager that delivers a higher return on investment than Spanish banks
Ricult: Providing smallholder farmers easier access to capital
Based in Pakistan and Thailand, Ricult’s mobile app platform provides advanced weather forecasting, easy loan applications and direct market access to help farmers increase productivity and profits
Dao Foods: Grooming and betting on China's rising alternative protein startups
How can businesses involve Chinese consumers in the environmental cause, even if it isn’t a priority for them? For that, the impact investor-incubator Dao Foods has got its philosophy-led strategy figured out
How Sequoia Capital China is helping its portfolio startups get through the Covid-19 crisis
The renowned investor is also making big bets on the opportunities that lie head
Supermarkets can now go cashierless too, with Mars Rabbit's scan & go app
Chinese startup gives traditional retailers the tech ammunition and chance to beat Amazon and Alibaba at their own game
Sorry, we couldn’t find any matches for“Point Nine Capital”.
POPULAR DATABASE
